| A variant in the CD209 promoter is associated with severity of dengue disease A Sakuntabhai, C Turbpaiboon, I Casadémont, A Chuansumrit, ... Nature genetics 37 (5), 507-513, 2005 | 398 | 2005 |
| TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation A Di Pietro, A Kajaste-Rudnitski, A Oteiza, L Nicora, GJ Towers, N Mechti, ... Journal of virology 87 (8), 4523-4533, 2013 | 259 | 2013 |
| Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy E Zonari, G Desantis, C Petrillo, FE Boccalatte, MR Lidonnici, ... Stem cell reports 8 (4), 977-990, 2017 | 167 | 2017 |
| D-mannose suppresses macrophage IL-1β production S Torretta, A Scagliola, L Ricci, F Mainini, S Di Marco, I Cuccovillo, ... Nature communications 11 (1), 1-12, 2020 | 154 | 2020 |
| Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking S Ferrari, A Jacob, S Beretta, G Unali, L Albano, V Vavassori, D Cittaro, ... Nature biotechnology 38 (11), 1298-1308, 2020 | 136 | 2020 |
| TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-κB-responsive long terminal repeat elements A Kajaste-Rudnitski, SS Marelli, C Pultrone, T Pertel, PD Uchil, N Mechti, ... Journal of virology 85 (10), 5183-5196, 2011 | 132 | 2011 |
| The 2′, 5′-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells A Kajaste-Rudnitski, T Mashimo, MP Frenkiel, JL Guénet, M Lucas, ... Journal of Biological Chemistry 281 (8), 4624-4637, 2006 | 131 | 2006 |
| Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression G Escobar, D Moi, A Ranghetti, P Ozkal-Baydin, ML Squadrito, ... Science translational medicine 6 (217), 217ra3-217ra3, 2014 | 122 | 2014 |
| Cyclosporine H overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells C Petrillo, LG Thorne, G Unali, G Schiroli, AMS Giordano, F Piras, ... Cell Stem Cell 23 (6), 820-832. e9, 2018 | 105 | 2018 |
| HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter F Turrini, S Marelli, A Kajaste-Rudnitski, M Lusic, C Van Lint, AT Das, ... Retrovirology 12 (1), 1-8, 2015 | 82 | 2015 |
| Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis M Chiriaco, G Farinelli, V Capo, E Zonari, S Scaramuzza, G Di Matteo, ... Molecular Therapy 22 (8), 1472-1483, 2014 | 82 | 2014 |
| M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication L Cassetta, A Kajaste-Rudnitski, T Coradin, E Saba, G Della Chiara, ... Aids 27 (12), 1847-1856, 2013 | 73 | 2013 |
| Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells C Petrillo, D Cesana, F Piras, S Bartolaccini, L Naldini, E Montini, ... Molecular Therapy 23 (2), 352-362, 2015 | 70 | 2015 |
| Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells F Piras, M Riba, C Petrillo, D Lazarevic, I Cuccovillo, S Bartolaccini, ... EMBO molecular medicine 9 (9), 1198-1211, 2017 | 68 | 2017 |
| DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes AMS Giordano, M Luciani, F Gatto, M Abou Alezz, C Beghè, L Della Volpe, ... Journal of Experimental Medicine 219 (4), e20211121, 2022 | 57 | 2022 |
| Lipid-based nanoparticles as nonviral gene delivery vectors D Pezzoli, A Kajaste-Rudnitski, R Chiesa, G Candiani Nanomaterial Interfaces in Biology, 269-279, 2013 | 55 | 2013 |
| Inhibition of influenza H5N1 invasion by modified heparin derivatives MA Skidmore, A Kajaste-Rudnitski, NM Wells, SE Guimond, TR Rudd, ... MedChemComm 6 (4), 640-646, 2015 | 49 | 2015 |
| Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cells A Kajaste-Rudnitski, L Naldini Human gene therapy 26 (4), 201-209, 2015 | 48 | 2015 |
| Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals A Kajaste-Rudnitski, L Galli, S Nozza, G Tambussi, A Di Pietro, ... Aids 25 (2), 177-183, 2011 | 48 | 2011 |
| Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′, 5′-oligoadenylate synthetase 1b E Mertens, A Kajaste-Rudnitski, S Torres, A Funk, MP Frenkiel, I Iteman, ... Virology 399 (1), 176-185, 2010 | 44 | 2010 |
Luigi NaldiniDirector, SR-TIGET, San Raffaele Telethon Institute for Gene Therapy, Professor of Tissue BiologyVerified email at hsr.it
